MARKET

RDHL

RDHL

Redhill Biopharm
NASDAQ
0.5000
-0.0204
-3.92%
After Hours: 0.5000 0 0.00% 16:30 09/25 EDT
OPEN
0.5251
PREV CLOSE
0.5204
HIGH
0.5251
LOW
0.5000
VOLUME
102.86K
TURNOVER
--
52 WEEK HIGH
2.790
52 WEEK LOW
0.5000
MARKET CAP
3.04M
P/E (TTM)
-3.5714
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RDHL last week (0914-0918)?
Weekly Report · 5d ago
Weekly Report: what happened at RDHL last week (0907-0911)?
Weekly Report · 09/14 10:02
RedHill Biopharma Pushes for Growth Securing Rights to Ferring’s $37M Gastrointestinal Drugs Portfolio
TipRanks · 09/08 14:49
Weekly Report: what happened at RDHL last week (0831-0904)?
Weekly Report · 09/07 09:57
RedHill Sells its Talicia® H. pylori Drug Business to Apotex in $18M Deal to Fuel Growth
TipRanks · 09/01 15:41
RedHill Biopharma Inks 13-Year Global Deal for Ferring’s Rebyota and U.S. Rights to Clenpiq
TipRanks · 09/01 11:30
RedHill acquires exclusive commercialization rights to Rebyota, Clenpiq for $12M
TipRanks · 09/01 11:20
RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota® and Clenpiq®
PR Newswire · 09/01 11:00
More
About RDHL
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.

Webull offers RedHill Biopharma Ltd (ADR) stock information, including NASDAQ: RDHL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RDHL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RDHL stock methods without spending real money on the virtual paper trading platform.